Revolution Medicines valuation

RVMD · NASDAQ · USD

Compare Revolution Medicines
$162.69Change from previous close: −2.50%Absolute change: −$4.18

Close · November 17, 2026

Valuation

The average price target of 24 analysts is $274.76.

Data as of November 15, 2026

Revolution Medicines compared with similar companies

Revolution Medicines's Price/book: 15.5, +92% against the median of a group of 11 similar companies (8.06).

Revolution Medicines's metrics compared with similar companies
MetricRevolution MedicinesMedian25th–75th percentileBand
Price/book15.58.065.30 – 13.1High
Price/sales188.69.446.70 – 15.0High
Gross margin0.0%77.3%57.9% – 90.7%Low
Operating margin-853.0%19.5%-48.6% – 32.1%Low
Net margin0.0%13.9%0.0% – 33.6%Middle
ROE-93.6%10.0%-8.4% – 37.8%Low
Debt/equity0.500.300.02 – 0.67Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$37.27B
Enterprise value
$34.83B
P/E (trailing 12 months)
-20.9
Forward P/E
-55.6
EV/EBITDA
-20.8
EV/revenue
176.3

Profitability and growth

ROA
-32.1%
ROIC
-30.7%

Financial health

Total cash
$3.65B
Total debt
$1.21B
Current ratio
8.36
Quick ratio
8.16
Altman Z-Score
6.63
Piotroski F-Score
2.00

Dividends

Dividend yield
0.0%

Analysts and estimates

Average price target
$274.76
Median price target
$272.00
High price target
$350.00
Low price target
$179.00
Analysts with a price target
24
Consensus
Strong buy
Forward EPS
-$3.10
EPS estimate, current year
-$8.30

Shares and trading

Beta
1.43
Average volume
2.18M
Shares outstanding
216.29M
Float
186.56M
Institutional ownership
103.9%
Insider ownership
3.9%
Short interest (% of float)
6.4%
Short ratio (days)
6.78